PHARBE 513
Clinical Development
Evaluates clinical development strategies including comprehensive drug candidate life cycle plan. Covers clinical trial design, FDA and Institutional Review Boards, ethics, consents, safety, and quality. Discusses target product profiles, phase III study synopses, informed consents, and SWOT analyses. Students present phase II results and debate go no go decisions. Offered: Sp.
Sources
- Course catalogue ↗Current public catalogue; retrieved 2026-11-05